Human breast cancer cells induce angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 11, 2000, Pages 631-640

  Winding, Bent ^a   Misander, Henriette ^a   Sveigaard, Christina ^a   Therkildsen, Bente ^a   Jakobsen, Maria ^a   Overgaard, Trine ^a   Oursler, Merry Jo ^b   Foged, Niels Tækker ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Bone metastasis; MDA 231 cells; Neo vascularization; Osteoclast recruitment; Osteolysis

Indexed keywords

ANGIOGENESIS; ARTICLE; BONE METASTASIS; BREAST CANCER; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0033784769     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008475     Document Type: Article

References (53)

1. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
2. A murine model of experimental metastasis to bone and bone marrow
3. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas
4. Microvessel quantitation and prognosis in invasive breast carcinoma
5. A novel in vitro assay for human angiogenesis
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis
8. Skeletal complications of malignancy
9. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
10. TGF beta-1 regulation of VEGF production by breast cancer cells
11. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
12. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse
13. The implications of angiogenesis for the biology and therapy of cancer metastasis
14. Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay
15. Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: A useful reagent for identifying and characterizing blood vessels and hematopoietic precursors
16. Parathyroid hormone-related protein and bone metastasis
17. Evidence for a clausal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
18. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
19. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
20. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
21. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
22. Clodronate decreases the frequency of skeletal metastases in women with breast cancer
23. IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release
24. Production and regulation of interleukin-11 by breast cancer cells
25. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis
26. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
27. Tumor vascular endothelium: Barrier or target in tumor directed drug delivery and immunotherapy
28. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors
29. Mechanisms of bone metastasis
30. The expression of vascular endothelial growth factor and transforming growth factor-beta associated with angiogenesis in epithelial ovarian cancer
31. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone
32. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta
33. Organ targeting in vivo using phage display peptide libraries
34. Alpha v integrins as receptors for tumor targeting by circulating ligands
35. Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness
36. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity
37. Advances in bone biology: The osteoclast
38. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
39. Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro
40. Vascular targeting as a strategy for cancer therapy
41. Tumor angiogensis and vascular endothelial growth factor expression in stage I lung adenocarcinoma
42. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system
43. Flk-1 as a target for tumor growth inhibition
44. Osteoblastic cells are involved in osteoclast formation
45. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors
46. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
47. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
48. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
49. Pituitary adenylyl cyclase-activating polypeptides and vasoactive intestinal peptide inhibit bone resorption by isolated rabbit osteoclasts
50. General mechanisms of metastasis
51. Osteolytic bone metastasis in breast cancer
52. Stromal cell effects on clonal growth of tumors